oncology medicine

Nupara (Rucaparib) 200mg and 300mg Tablets is a targeted anticancer medicine belonging to the PARP inhibitor class. It is used in the treatment of certain ovarian, fallopian tube, primary peritoneal, and BRCA-mutated metastatic prostate cancers. Rucaparib works by blocking DNA repair in cancer cells, helping slow disease progression. Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical exporter in India, supplying quality oncology medicines with fast and secure delivery to: United States, Germany, United Kingdom, South Africa, United Arab Emirates, Brazil, Singapore, Australia, and Canada. Uses of Nupara (Rucaparib) Nupara may be prescribed for: Recurrent ovarian cancer Fallopian tube cancer Primary peritoneal cancer BRCA-mutated metastatic prostate cancer Maintenance therapy after response to platinum-based chemotherapy Available Strengths Nupara 200mg Tablets Nupara 300mg Tablets Recommended Dosage Typical adult dose: 600mg twice daily Taken orally with or without food Dosage adjustments may be required based on patient response and side effects Use only under the supervision of an oncologist Common Side Effects Patients may experience: Nausea and vomiting Fatigue Loss of appetite Diarrhea or constipation Abdominal pain Anemia Shortness of breath Changes in liver function tests Seek immediate medical attention for severe bleeding, persistent fever, or signs of serious blood disorders. Why Choose Cordium Pharmaceuticals Pvt Ltd? ✔ Trusted oncology medicine exporter from India ✔ Competitive pricing ✔ Genuine pharmaceutical products ✔ Fast international shipping ✔ Secure packaging ✔ Bulk supply for hospitals and distributors ✔ Documentation support for global exports FAQs What is Nupara used for? Nupara (Rucaparib) is used for certain ovarian, fallopian tube, primary peritoneal, and BRCA-mutated prostate cancers. Is Nupara chemotherapy? No. It is a targeted therapy known as a PARP inhibitor. Can Nupara be taken with food? Yes, it can be taken with or without food. What are the common side effects? Common side effects include nausea, fatigue, anemia, appetite loss, constipation, and diarrhea. Can Cordium Pharmaceuticals export Nupara internationally? Yes. We supply and export oncology medicines to the USA, Germany, UK, South Africa, UAE, Brazil, Singapore, Australia, Canada, and other global markets. Contact Cordium Pharmaceuticals Pvt Ltd For pricing, bulk orders, and international supply of Nupara (Rucaparib) 200mg & 300mg Tablets, contact Cordium Pharmaceuticals Pvt Ltd, your trusted oncology medicine exporter from India.

Ibrunat (Ibrutinib) 140mg Capsules Ibrunat 140mg Capsules contain Ibrutinib 140mg, a targeted anticancer medicine used in the treatment of specific blood cancers and lymphatic system disorders. Ibrutinib belongs to a class of medicines known as Bruton's Tyrosine Kinase (BTK) inhibitors, which help slow or stop the growth of cancer cells. Manufactured & Exported by Cordium Pharmaceuticals Pvt Ltd Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical exporter in India, supplying high-quality oncology medicines to healthcare providers, distributors, pharmacies, and importers worldwide. We offer: Genuine oncology medicines Competitive export pricing Regulatory documentation support Secure packaging Fast international delivery Worldwide shipping assistance What is Ibrunat 140mg Used For? Ibrunat (Ibrutinib) is prescribed for the treatment of: Chronic Lymphocytic Leukemia (CLL) Small Lymphocytic Lymphoma (SLL) Mantle Cell Lymphoma (MCL) Waldenström's Macroglobulinemia (WM) Marginal Zone Lymphoma (MZL) Chronic Graft-versus-Host Disease (cGVHD) in eligible patients How Ibrutinib Works Ibrutinib blocks the activity of Bruton's Tyrosine Kinase (BTK), a protein that helps certain cancerous B-cells survive and multiply. By inhibiting BTK, Ibrutinib slows cancer progression and promotes the destruction of malignant cells. Recommended Dosage The dosage of Ibrunat should always be determined by an oncologist based on the patient's condition and treatment plan. Common dosage regimens include: 420 mg once daily for CLL, SLL, WM, and cGVHD 560 mg once daily for certain Mantle Cell Lymphoma indications Patients should: Take capsules exactly as prescribed Swallow capsules whole with water Take the medicine at the same time each day Avoid grapefruit and grapefruit juice during treatment Important: Never adjust the dose without medical supervision. Possible Side Effects Like all cancer medicines, Ibrunat may cause side effects. Common Side Effects Diarrhea Nausea Fatigue Headache Muscle or joint pain Rash Bruising Fever Mouth sores Serious Side Effects Seek immediate medical attention if you experience: Unusual bleeding Severe infections Irregular heartbeat Shortness of breath Severe allergic reactions Persistent fever Significant decrease in blood cell counts Storage Information Store below 30°C Keep in the original packaging Protect from moisture and direct sunlight Keep out of reach of children Why Choose Cordium Pharmaceuticals Pvt Ltd? Trusted Oncology Medicine Exporter from India Cordium Pharmaceuticals Pvt Ltd specializes in supplying high-quality oncology and specialty medicines globally. Our Advantages ✓ Reliable sourcing and quality assurance ✓ Competitive wholesale export prices ✓ Fast order processing ✓ Secure international packaging ✓ Global logistics support ✓ Professional export documentation ✓ Dedicated customer assistance Countries We Export To Cordium Pharmaceuticals Pvt Ltd supplies Ibrunat (Ibrutinib) 140mg Capsules with fast international delivery to: United States Germany United Kingdom South Africa United Arab Emirates Brazil Singapore Australia Canada Request a Quote for Ibrunat 140mg Capsules Looking for a reliable supplier of Ibrutinib 140mg Capsules from India? Cordium Pharmaceuticals Pvt Ltd offers dependable export solutions for hospitals, distributors, pharmacies, healthcare providers, and licensed importers worldwide. Contact us today for pricing, availability, and international shipping information for Ibrunat (Ibrutinib) 140mg Capsules.

Dasatrue 50mg & 70mg Tablets Exporter from India Cordium Pharmaceuticals Pvt. Ltd. is a trusted pharmaceutical exporter and supplier of Dasatrue Tablets 50mg and 70mg (Dasatinib) from India. We provide high-quality oncology medicines with secure packaging, competitive pricing, and fast international delivery to healthcare providers, pharmacies, hospitals, and licensed importers worldwide. International Delivery Available To: United States Germany United Kingdom South Africa United Arab Emirates Brazil Singapore Australia Canada What is Dasatrue? Dasatrue Tablets contain Dasatinib, a tyrosine kinase inhibitor (TKI) used in the treatment of certain blood cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive (Ph+) leukemias. Dasatinib works by blocking abnormal proteins that promote cancer cell growth and multiplication. Available Strengths Dasatrue 50mg Tablet Dasatrue 70mg Tablet Uses of Dasatrue Tablets Dasatrue (Dasatinib) is indicated for: Chronic Myeloid Leukemia (CML) in chronic phase Accelerated phase CML Myeloid or lymphoid blast phase CML Newly diagnosed Philadelphia chromosome-positive CML Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) under physician supervision How Dasatrue Works Dasatinib inhibits specific cancer-causing enzymes known as BCR-ABL tyrosine kinases, helping to slow or stop the growth of leukemia cells. This targeted action assists in controlling disease progression and improving patient outcomes. Dosage and Administration Dasatrue 50mg Dosage should be determined by the treating oncologist. Taken orally once daily with or without food. Swallow the tablet whole with water. Dasatrue 70mg Commonly prescribed according to disease stage and patient response. Take at the same time each day for optimal effectiveness. Do not crush, chew, or split the tablet. Important Instructions Follow your physician's prescription strictly. Regular blood monitoring may be required. Do not discontinue treatment without medical advice. Avoid self-medication or dosage adjustments. Common Side Effects of Dasatrue Patients may experience: Headache Nausea Vomiting Fatigue Muscle pain Joint pain Rash Abdominal pain Diarrhea Anemia Low platelet count Increased risk of infections Fluid retention (edema) Pleural effusion (fluid around the lungs) Serious Side Effects (Seek Immediate Medical Attention) Severe bleeding Shortness of breath Pulmonary hypertension Heart-related complications Severe allergic reactions Significant blood count abnormalities Precautions Not recommended during pregnancy. Avoid breastfeeding during treatment. Use effective contraception during therapy. Inform your doctor about all medications being taken. Liver function and blood counts should be monitored regularly. Why Choose Cordium Pharmaceuticals Pvt. Ltd.? Trusted Indian Pharmaceutical Exporter Cordium Pharmaceuticals Pvt. Ltd. delivers quality oncology medicines globally with: ✅ Reliable sourcing and quality assurance ✅ Competitive export pricing ✅ Fast worldwide shipping ✅ Professional export documentation support ✅ Secure packaging for international transit ✅ Dedicated customer support team ✅ Bulk order and institutional supply capabilities Global Export & Fast Delivery Cordium Pharmaceuticals Pvt. Ltd. supplies Dasatrue Tablets to importers, distributors, hospitals, pharmacies, and healthcare organizations across: United States Germany United Kingdom South Africa United Arab Emirates Brazil Singapore Australia Canada Contact Cordium Pharmaceuticals Pvt. Ltd. Looking for a reliable Dasatrue 50mg & 70mg supplier from India? Cordium Pharmaceuticals Pvt. Ltd. offers dependable international pharmaceutical export services, ensuring timely delivery and regulatory-compliant supply of oncology medicines worldwide.

Acalabrutinib 100 mg Capsules Acalabrutinib 100 mg Capsules are a targeted anti-cancer medication used in the treatment of specific blood cancers, including Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), and Mantle Cell Lymphoma (MCL). Acalabrutinib belongs to a class of medicines known as Bruton's Tyrosine Kinase (BTK) inhibitors, which work by blocking signals that help cancer cells grow and survive. Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical exporter from India, supplying high-quality oncology medicines to hospitals, distributors, pharmacies, and healthcare providers across global markets. What is Acalabrutinib? Acalabrutinib is an oral targeted therapy that selectively inhibits Bruton's Tyrosine Kinase (BTK), a protein involved in the growth and survival of malignant B-cells. By blocking BTK activity, Acalabrutinib helps slow or stop the progression of certain blood cancers. Therapeutic Uses of Acalabrutinib 100 mg Capsules Acalabrutinib is prescribed for the treatment of: 1. Chronic Lymphocytic Leukemia (CLL) A common type of leukemia affecting mature white blood cells. 2. Small Lymphocytic Lymphoma (SLL) A closely related cancer that primarily affects lymph nodes. 3. Mantle Cell Lymphoma (MCL) An aggressive form of non-Hodgkin lymphoma affecting B lymphocytes. How Acalabrutinib Works Acalabrutinib targets and blocks BTK (Bruton's Tyrosine Kinase), a critical enzyme involved in cancer cell signaling. This action disrupts the survival and proliferation of cancerous B-cells, helping control disease progression. Recommended Dosage Standard Adult Dose: Acalabrutinib 100 mg orally Taken twice daily (every 12 hours) Can be taken with or without food Capsules should be swallowed whole with water Do not crush, chew, or open the capsules Treatment should continue as directed by the treating oncologist until disease progression or unacceptable toxicity occurs. Missed Dose Instructions If less than 3 hours have passed, take the missed dose immediately. If more than 3 hours have passed, skip the missed dose and continue the regular schedule. Do not take a double dose. Common Side Effects Patients may experience: Headache Diarrhea Nausea Fatigue Muscle pain Joint pain Constipation Mild bruising Rash Most side effects are manageable and should be discussed with a healthcare professional if persistent. Serious Side Effects Seek immediate medical attention if any of the following occur: Severe or unusual bleeding Fever or signs of infection Irregular heartbeat or palpitations Shortness of breath Severe dizziness Liver problems (yellowing of skin or eyes) Severe allergic reactions Regular monitoring by a healthcare provider is recommended during treatment. Precautions & Warnings Before taking Acalabrutinib, inform your healthcare provider if you have: Bleeding disorders Heart disease or arrhythmias Active infections Liver impairment Recent surgery Pregnancy or breastfeeding Patients should avoid grapefruit products and consult their physician regarding potential drug interactions. Storage Information Store at room temperature (20°C–25°C) Keep away from moisture and direct sunlight Keep out of reach of children Why Choose Cordium Pharmaceuticals Pvt Ltd? Cordium Pharmaceuticals Pvt Ltd is a reliable Indian pharmaceutical exporter committed to delivering high-quality oncology medicines worldwide. Our Strengths Trusted global exporter from India Quality-assured oncology products Competitive international pricing Reliable supply chain management Export documentation support Timely worldwide delivery Partner-focused distribution solutions We serve pharmaceutical importers, hospitals, government tenders, wholesalers, and oncology healthcare providers across international markets. Contact Cordium Pharmaceuticals Pvt Ltd For bulk orders, export inquiries, product registration support, or distributor partnerships for Acalabrutinib 100 mg Capsules, contact Cordium Pharmaceuticals Pvt Ltd today and benefit from dependable global pharmaceutical supply solutions. Disclaimer: This content is intended for informational purposes only and should not replace professional medical advice. Acalabrutinib must be used only under the supervision of a qualified healthcare professional.

Pryor (Apalutamide) 60 mg Tablets by Cordium Pharmaceuticals Pvt. Ltd. Pryor (Apalutamide) 60 mg Tablets is an anti-androgen medicine used in the treatment of specific types of prostate cancer. Manufactured and exported by Cordium Pharmaceuticals Pvt. Ltd., Pryor contains Apalutamide 60 mg, an androgen receptor inhibitor that helps slow the growth and spread of prostate cancer cells by blocking the action of male hormones (androgens). As a reliable pharmaceutical exporter from India, Cordium Pharmaceuticals provides quality-assured oncology medicines with secure packaging, competitive pricing, and fast international delivery. What is Pryor (Apalutamide) 60 mg Used For? Pryor (Apalutamide) is prescribed for the treatment of: Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Advanced prostate cancer as part of androgen deprivation therapy (ADT) under physician supervision. How Apalutamide Works Apalutamide blocks androgen receptors that prostate cancer cells need to grow and survive. By preventing these hormones from activating cancer cells, Pryor helps delay disease progression and improve treatment outcomes. Dosage and Administration Recommended Dosage The standard recommended dose of Apalutamide is 240 mg once daily. Since each Pryor tablet contains 60 mg, the usual dose is 4 tablets once daily, or as prescribed by the treating oncologist. Tablets may be taken with or without food. Swallow tablets whole with water. Do not crush, break, or chew the tablets unless specifically instructed by a healthcare professional. Missed Dose If a dose is missed, take it as soon as remembered on the same day. If it is nearly time for the next dose, skip the missed dose and continue the regular schedule. Do not take a double dose. Benefits of Pryor (Apalutamide) 60 mg Helps slow the progression of prostate cancer Reduces androgen receptor signaling Supports long-term prostate cancer management Convenient once-daily dosing Widely used in combination with androgen deprivation therapy (ADT) Manufactured under stringent quality standards in India Possible Side Effects Like all medicines, Pryor (Apalutamide) may cause side effects. Commonly reported side effects include: Fatigue or weakness Skin rash Joint pain Hot flashes Weight loss Diarrhea High blood pressure Decreased appetite Increased risk of falls and fractures Serious Side Effects Seek immediate medical attention if you experience: Seizures Severe allergic reactions Chest pain or signs of heart problems Stroke symptoms Severe skin reactions with blistering or peeling Persistent breathing difficulties Precautions Use only under the supervision of a qualified oncologist. Inform your doctor about any history of seizures, cardiovascular disease, stroke, or osteoporosis. Regular monitoring of blood pressure and overall health is recommended during treatment. Patients should discuss fertility and reproductive precautions with their healthcare provider. Why Choose Cordium Pharmaceuticals Pvt. Ltd.? Trusted Oncology Medicine Exporter from India Cordium Pharmaceuticals Pvt. Ltd. is committed to supplying high-quality pharmaceutical products worldwide. Our Advantages WHO-GMP compliant manufacturing partners International export documentation support Competitive global pricing Reliable supply chain management Secure packaging for international shipments Dedicated customer support Bulk order and distributor inquiries welcome Global Export & Fast Delivery Cordium Pharmaceuticals offers prompt export services and worldwide shipping of Pryor (Apalutamide) 60 mg Tablets to: United States Germany United Kingdom South Africa United Arab Emirates Brazil Singapore Australia Canada We work with trusted international logistics partners to ensure timely and secure delivery of pharmaceutical products to hospitals, pharmacies, distributors, and healthcare organizations worldwide. Product Information Product Name Pryor Generic Name Apalutamide Strength 60 mg Dosage Form Tablets Therapeutic Category Oncology / Anti-Androgen Indication Prostate Cancer Packaging As per export requirements Manufacturer/Exporter Cordium Pharmaceuticals Pvt. Ltd., India Contact Cordium Pharmaceuticals Pvt. Ltd. For bulk orders, distributor partnerships, import inquiries, and international supply of Pryor (Apalutamide) 60 mg Tablets, contact Cordium Pharmaceuticals Pvt. Ltd., a trusted exporter of oncology medicines from India. Disclaimer: This content is intended for informational purposes only and should not replace professional medical advice. Pryor (Apalutamide) 60 mg Tablets should be used only under the guidance of a qualified healthcare professional.

About Giotrif (Afatinib) Tablets Giotrif (active ingredient: Afatinib) is a prescription anti-cancer targeted therapy used in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR gene mutations. It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking signals that cause cancer cell growth and spread. Cordium Pharmaceuticals Pvt. Ltd. is a trusted Indian pharmaceutical exporter supplying high-quality oncology medicines to regulated and semi-regulated global markets. Available Strengths Giotrif 20mg Tablets Giotrif 30mg Tablets Giotrif 40mg Tablets Each tablet contains Afatinib Dimaleate as the active pharmaceutical ingredient. Therapeutic Uses Giotrif (Afatinib) is prescribed for: Non-small cell lung cancer (NSCLC) EGFR mutation-positive metastatic lung cancer Squamous cell lung cancer (after chemotherapy failure) Advanced or locally metastatic lung tumors (as directed by oncologist) How Giotrif Works Giotrif blocks EGFR and ErbB family receptors, which are responsible for cancer cell growth and survival. By inhibiting these pathways, it helps: Slow tumor progression Reduce cancer cell proliferation Improve treatment outcomes in targeted patients Recommended Dosage ⚠️ Only to be used under strict medical supervision Standard starting dose: 40mg once daily Dose may be adjusted to 30mg or 20mg depending on patient tolerance Must be taken on an empty stomach Take at least 1 hour before or 2–3 hours after food Possible Side Effects Like all oncology medicines, Giotrif may cause side effects, including: Common Side Effects Diarrhea Skin rash or acne-like eruption Mouth ulcers / stomatitis Loss of appetite Dry skin Serious Side Effects (Require Medical Attention) Severe dehydration due to diarrhea Liver function abnormalities Breathing difficulties (rare lung inflammation) Severe skin reactions or blistering Storage Instructions Store below 25°C Keep in original packaging Protect from moisture and sunlight Keep out of reach of children Global Export Markets Cordium Pharmaceuticals Pvt. Ltd. proudly exports Giotrif tablets to: United States 🇺🇸 Germany 🇩🇪 United Kingdom 🇬🇧 Canada 🇨🇦 Australia 🇦🇺 United Arab Emirates 🇦🇪 Singapore 🇸🇬 Brazil 🇧🇷 South Africa 🇿🇦 We ensure safe packaging, regulatory compliance, and fast international shipping. Why Choose Cordium Pharmaceuticals Pvt. Ltd.? WHO-GMP compliant sourcing standards Reliable global pharmaceutical exporter from India Strong supply chain for oncology medicines Fast and secure international delivery Quality assurance and batch traceability Important Medical Disclaimer Giotrif (Afatinib) is a prescription-only oncology medicine. It must be used strictly under the supervision of a qualified healthcare professional. This product page is intended for educational and export information purposes only. Contact & Export Inquiry For bulk export, distributor pricing, or regulatory documentation: Cordium Pharmaceuticals Pvt. Ltd. (India) 📦 Export Inquiry: Available for global pharmaceutical distributors 🌍 Shipping: Worldwide (regulated & semi-regulated markets)

Axitinib Tablets 1 mg & 5 mg High-Quality Oncology API Formulation by Cordium Pharmaceuticals Pvt. Ltd. Cordium Pharmaceuticals Pvt. Ltd. is a trusted pharmaceutical manufacturer and exporter in India, delivering high-quality oncology medicines to global markets. Our Axitinib Tablets (1 mg & 5 mg) are formulated to support treatment protocols for advanced renal cell carcinoma (kidney cancer) under strict quality and regulatory compliance. What is Axitinib? Axitinib is an oral targeted cancer therapy (tyrosine kinase inhibitor) that works by blocking vascular endothelial growth factor receptors (VEGFR). This helps in slowing or stopping the growth of cancer cells by reducing blood supply to tumors. Uses of Axitinib Tablets Axitinib is primarily prescribed for: Treatment of advanced renal cell carcinoma (RCC) Management of kidney cancer after failure of first-line therapy Used in combination therapy in some oncology protocols (as per physician advice) How Axitinib Works Axitinib inhibits VEGFR-1, VEGFR-2, and VEGFR-3 receptors, which are responsible for tumor angiogenesis (formation of blood vessels supplying tumors). By blocking these pathways, Axitinib: Reduces tumor growth Restricts cancer cell proliferation Slows disease progression Recommended Dosage ⚠️ Dosage must always be prescribed by a qualified oncologist. Typical adult dosage guidelines: Starting dose: 5 mg twice daily (every 12 hours) Available strengths: 1 mg and 5 mg tablets for dose adjustment Tablets should be swallowed whole with water Can be taken with or without food Avoid grapefruit or grapefruit juice during treatment Dose may be adjusted based on: Patient tolerance Blood pressure levels Side effects Clinical response Side Effects of Axitinib Tablets Like all oncology medicines, Axitinib may cause side effects. Common Side Effects: High blood pressure (hypertension) Fatigue and weakness Nausea, vomiting Diarrhea or constipation Loss of appetite Weight loss Hoarseness or voice changes Skin dryness or rash Serious Side Effects (Seek medical attention): Severe bleeding Chest pain or heart problems Blood clots Severe headache or vision changes Liver function abnormalities Kidney problems Severe gastrointestinal perforation (rare) Warnings & Precautions Regular blood pressure monitoring required Not recommended during pregnancy or breastfeeding Use effective contraception during treatment Avoid in patients with severe liver or heart disease without supervision Inform doctor before surgery or dental procedures Storage Instructions Store below 25°C in a dry place Protect from moisture and direct sunlight Keep out of reach of children Use only under prescription Quality Assurance – Cordium Pharmaceuticals Pvt. Ltd. Cordium Pharmaceuticals ensures: WHO-GMP compliant manufacturing practices Strict quality control testing Stable and validated formulations Export-grade packaging standards Global pharmaceutical supply capability We are committed to delivering safe, effective, and affordable oncology medicines worldwide.

What is Cazanat (Cabozantinib)? Cazanat Tablets contain Cabozantinib, a potent tyrosine kinase inhibitor (TKI) used in oncology for the treatment of advanced cancers. It works by blocking abnormal cancer cell growth and inhibiting the formation of new blood vessels that supply tumors. Cazanat is available in strengths: 20 mg Tablets 40 mg Tablets 60 mg Tablets Manufactured and exported by Cordium Pharmaceuticals Pvt. Ltd., India, a trusted pharmaceutical exporter delivering high-quality oncology medicines globally. Therapeutic Uses of Cazanat (Cabozantinib) Cazanat is prescribed for the treatment of: Renal Cell Carcinoma (RCC) – advanced kidney cancer Hepatocellular Carcinoma (HCC) – liver cancer Medullary Thyroid Cancer (MTC) Metastatic Thyroid Cancer (DTC) Neuroendocrine Tumors (NETs) in selected cases How Cazanat Works (Mechanism of Action) Cabozantinib targets multiple receptor pathways involved in cancer progression: Inhibits VEGFR (vascular endothelial growth factor receptor) Blocks MET and AXL kinases Reduces tumor angiogenesis (blood vessel formation) Slows tumor growth and metastasis Dosage & Administration ⚠️ Important: Dosage must always be decided by an oncologist. General Dosage Guidelines Usually once daily oral tablet Taken on an empty stomach Swallow whole with water (do not crush or chew) Strength Selection 20mg – dose adjustment or mild tolerance cases 40mg – standard intermediate therapy 60mg – full therapeutic dose in advanced cancer cases Missed Dose Take as soon as remembered unless close to next dose Do not double dose Common Side Effects of Cazanat Like most oncology drugs, Cazanat may cause side effects: Very Common Fatigue and weakness Loss of appetite Nausea and vomiting Diarrhea or constipation Weight loss Mouth sores Skin & Hair Effects Hand-foot syndrome (redness, pain, peeling) Dry skin Hair thinning or color changes Serious Side Effects (Require Medical Attention) High blood pressure Bleeding problems Severe abdominal pain Blood clots Liver function abnormalities Difficulty breathing Warnings & Precautions Before using Cazanat, inform your doctor if you have: Heart disease or hypertension Liver or kidney disorders History of bleeding disorders Recent surgery or wound healing issues Important Safety Notes Not recommended during pregnancy or breastfeeding Effective contraception required during treatment Regular blood pressure monitoring is essential Drug Interactions Cazanat may interact with: Strong CYP3A4 inhibitors/inducers Blood pressure medications Anticoagulants (blood thinners) Certain antifungal and antibiotic drugs Always inform your healthcare provider about all medicines you are taking. Storage Instructions Store below 25°C Keep away from moisture and sunlight Keep out of reach of children Do not use expired medicine Why Choose Cordium Pharmaceuticals Pvt. Ltd.? Cordium Pharmaceuticals is a trusted Indian pharmaceutical exporter specializing in oncology and life-saving medicines. Key Highlights: WHO-GMP compliant sourcing High-quality oncology formulations Export-ready packaging standards Global supply capabilities Strict quality assurance systems Disclaimer This information is for educational and SEO purposes only. Cazanat (Cabozantinib) is a prescription-only medicine and must be used strictly under medical supervision.

ETIBO 250 mg Tablets ETIBO 250 mg Tablets contain Lapatinib 250 mg, a targeted anti-cancer medicine used in the treatment of HER2-positive breast cancer. ETIBO is widely prescribed as part of advanced oncology treatment protocols to help slow the growth and spread of cancer cells by targeting HER2 and EGFR receptors. As a trusted pharmaceutical exporter, Cordium Pharmaceuticals Pvt Ltd supplies ETIBO 250 mg Tablets to global markets with a commitment to quality, regulatory compliance, and timely delivery. Product Information Product Name ETIBO 250 mg Tablets Generic Name Lapatinib Strength 250 mg Dosage Form Oral Tablets Therapeutic Category Oncology / Anti-Cancer Drug Class Tyrosine Kinase Inhibitor (TKI) Indication HER2-Positive Breast Cancer Manufacturer Samarth Life Sciences Pvt Ltd Exporter Cordium Pharmaceuticals Pvt Ltd, India ETIBO 250 mg Tablets contain Lapatinib, a targeted therapy that inhibits HER2 and EGFR signaling pathways involved in cancer cell growth and proliferation. What is ETIBO 250 mg Tablet? ETIBO 250 mg Tablet is an oral anti-cancer medication used for the treatment of HER2-positive advanced or metastatic breast cancer. It is commonly prescribed alone or in combination with other anti-cancer medicines such as capecitabine or letrozole under specialist supervision. Therapeutic Uses of ETIBO 250 mg ETIBO Tablets are used for: HER2-positive advanced breast cancer Metastatic breast cancer Hormone receptor-positive, HER2-positive breast cancer Combination therapy with capecitabine Combination therapy with letrozole Patients who have received prior anti-cancer treatments and require targeted therapy Mechanism of Action Lapatinib is a dual tyrosine kinase inhibitor that blocks: HER2 (Human Epidermal Growth Factor Receptor 2) EGFR (Epidermal Growth Factor Receptor) By inhibiting these receptors, ETIBO helps prevent cancer cell signaling, reducing tumor growth and slowing disease progression. Benefits of ETIBO 250 mg Tablets Targeted Cancer Therapy Specifically targets HER2-positive cancer cells while minimizing effects on healthy tissues. Oral Administration Convenient tablet dosage form for long-term treatment. Proven Oncology Treatment Widely used in advanced breast cancer treatment protocols. Effective Combination Therapy Can be combined with other oncology medicines to enhance treatment outcomes. Global Quality Standards Manufactured under stringent pharmaceutical quality systems and supplied through reliable export channels. Dosage and Administration Take strictly as prescribed by an oncologist. Usually administered on an empty stomach. Tablets should be swallowed whole with water. Do not crush, chew, or break the tablet. Continue treatment for the duration recommended by your healthcare provider. Important: Dosage may vary depending on patient condition, treatment response, and combination therapy requirements. Storage Conditions Store below 30°C. Protect from moisture and direct sunlight. Keep in original packaging. Keep out of reach of children. Possible Side Effects Like other oncology medicines, ETIBO may cause certain side effects, including: Diarrhea Nausea Vomiting Fatigue Rash Headache Loss of appetite Weakness Hand-foot syndrome Shortness of breath Patients should seek immediate medical attention if severe side effects occur. Regular monitoring of liver function and cardiac health may be recommended during treatment. Why Choose Cordium Pharmaceuticals Pvt Ltd? Cordium Pharmaceuticals Pvt Ltd is a trusted exporter of oncology medicines from India, offering: Reliable international pharmaceutical supply Competitive export pricing WHO-GMP quality standards Regulatory documentation support Customized export packaging Bulk supply capabilities Timely global shipments Dedicated customer service We work with distributors, hospitals, government procurement agencies, and healthcare organizations worldwide. Global Export Markets Cordium Pharmaceuticals Pvt Ltd exports ETIBO 250 mg Tablets to: Africa Middle East Southeast Asia Latin America CIS Countries Europe (subject to country regulations) Frequently Asked Questions What is ETIBO 250 mg Tablet used for? ETIBO 250 mg Tablet is used for the treatment of HER2-positive advanced or metastatic breast cancer. What is the active ingredient in ETIBO? The active pharmaceutical ingredient in ETIBO is Lapatinib 250 mg. Is ETIBO a chemotherapy medicine? No. ETIBO contains Lapatinib, which is a targeted therapy belonging to the tyrosine kinase inhibitor class of anti-cancer medicines. Can ETIBO be used with other cancer medicines? Yes. It is frequently prescribed in combination with capecitabine or letrozole as part of a comprehensive treatment plan. Does Cordium Pharmaceuticals export ETIBO internationally? Yes. Cordium Pharmaceuticals Pvt Ltd supplies ETIBO 250 mg Tablets to international pharmaceutical markets with complete export support.

Lenvatol 4mg/10mg Capsules Lenvatol 4mg/10mg Capsules contain Lenvatinib, a prescription medicine used under the supervision of qualified healthcare professionals. Cordium Pharmaceuticals Pvt Ltd is a trusted exporter and supplier of Lenvatol Capsules from India, offering reliable international shipping, competitive pricing, quality packaging, and fast delivery to customers worldwide. We specialize in exporting pharmaceutical products to the USA, UK, UAE, South Africa, Canada, Singapore, and other international markets while maintaining high standards of product quality and regulatory compliance. Product Information Product Name: Lenvatol Capsules Strengths Available: 4mg and 10mg Generic Name: Lenvatinib Capsules Dosage Form: Oral Capsules Packaging: Export Quality Packaging Manufacturer/Exporter: Cordium Pharmaceuticals Pvt Ltd Country of Origin: India Key Features of Lenvatol 4mg/10mg Capsules High-quality pharmaceutical formulation Available in 4mg and 10mg strengths Secure and tamper-proof packaging Competitive export pricing Bulk and wholesale supply available Fast international shipping Reliable documentation support for exports Worldwide delivery services Why Choose Cordium Pharmaceuticals Pvt Ltd? Cordium Pharmaceuticals Pvt Ltd is committed to delivering quality pharmaceutical products to international buyers, distributors, pharmacies, healthcare institutions, and importers. Our extensive export network enables us to provide dependable supply solutions and timely deliveries across global markets. Our Advantages Trusted pharmaceutical exporter from India Competitive wholesale prices Fast order processing Professional export documentation Dedicated customer support International logistics expertise Secure packaging for global transit Export Markets We offer fast and reliable export services for Lenvatol 4mg/10mg Capsules to: USA Efficient pharmaceutical export solutions with secure packaging and dependable logistics support. United Kingdom (UK) Reliable supply chain management and timely delivery for pharmaceutical importers and distributors. United Arab Emirates (UAE) Quick shipping and professional export services for healthcare and pharmaceutical businesses. South Africa Trusted pharmaceutical exports with quality assurance and competitive pricing. Canada Professional export handling and prompt delivery for pharmaceutical procurement requirements. Singapore Efficient international shipping with comprehensive export support and documentation. Packaging & Shipping Cordium Pharmaceuticals Pvt Ltd ensures that all shipments are packed according to international standards to maintain product integrity during transportation. We work with reputable logistics partners to facilitate safe and timely deliveries worldwide. Shipping Benefits Fast dispatch Secure export packaging Worldwide delivery Tracking support Bulk shipment capability International documentation assistance Wholesale & Bulk Orders We welcome inquiries from: Pharmaceutical distributors Importers Wholesalers Hospitals Healthcare organizations Government procurement agencies International pharmaceutical buyers Bulk order pricing and long-term supply agreements are available upon request. Quality Commitment Cordium Pharmaceuticals Pvt Ltd follows strict quality standards and works to ensure product consistency, secure packaging, and customer satisfaction. Our team is dedicated to supporting global buyers with dependable pharmaceutical export solutions. Request a Quote Looking for a reliable supplier and exporter of Lenvatol 4mg/10mg Capsules from India? Contact Cordium Pharmaceuticals Pvt Ltd today for: Latest pricing Bulk order inquiries Export documentation support International shipping information Distributor opportunities Get fast responses, competitive quotations, and dependable pharmaceutical export services worldwide.

Azacitidine Tablets are prescription anti-cancer medicines used in the management of specific blood cancers and bone marrow disorders. Azacitidine belongs to the class of hypomethylating agents that help slow or stop the growth of abnormal blood cells and support normal blood cell production. Product Information Product Name Azacitidine Tablets Strengths 200 mg, 300 mg Dosage Form Oral Tablets Therapeutic Category Antineoplastic Agent Route of Administration Oral Prescription Status Rx Only Uses of Azacitidine Tablets Azacitidine Tablets are indicated for the treatment of: Acute Myeloid Leukemia (AML) in patients who have achieved remission and require maintenance therapy. Certain myelodysplastic syndromes (MDS) and related hematological disorders, as advised by a qualified oncologist or hematologist. Patients who are not suitable candidates for intensive curative treatment or require long-term maintenance therapy. Mechanism of Action Azacitidine works by modifying abnormal DNA methylation patterns in cancer cells. This helps restore normal gene function, inhibits the growth of malignant cells, and promotes the formation of healthy blood cells. Dosage & Administration Important: Use only under the supervision of an oncologist. Take the tablet exactly as prescribed by your physician. Swallow the tablet whole with water. Do not crush, chew, or split the tablet. It may be taken with or without food. Treatment is generally administered in cycles as determined by the treating physician. If a dose is missed, consult your healthcare provider for guidance. Do not double the dose. Precautions & Warnings Before taking Azacitidine Tablets, inform your doctor if you: Are pregnant, planning pregnancy, or breastfeeding. Have liver, kidney, or heart disorders. Have a history of severe infections. Are taking other prescription medicines, herbal supplements, or over-the-counter products. Special Precautions Regular blood count monitoring is required during treatment. The medicine may reduce white blood cells, red blood cells, and platelets, increasing the risk of infections and bleeding. Avoid close contact with individuals who have contagious infections. Effective contraception is recommended during treatment and for a specified period after therapy. Patients should immediately report fever, unusual bleeding, bruising, or signs of infection to their healthcare provider. Possible Side Effects Like all medicines, Azacitidine Tablets may cause side effects, although not everyone experiences them. Common Side Effects Nausea Vomiting Diarrhea Constipation Loss of appetite Fatigue or weakness Abdominal discomfort Joint or muscle pain Serious Side Effects Seek immediate medical attention if you experience: Fever or signs of infection Unusual bruising or bleeding Blood in urine or stools Severe fatigue Difficulty breathing Allergic reactions such as rash, swelling, or breathing difficulty Significant reduction in blood cell counts Storage Instructions Store below 25°C in a dry place. Protect from moisture and direct sunlight. Keep out of reach of children. Do not use after the expiry date mentioned on the pack. Why Choose Cordium Pharmaceuticals? Commitment to oncology-focused healthcare solutions Stringent quality standards and manufacturing practices Reliable supply chain and product consistency Dedicated support for healthcare professionals and institutions Disclaimer Azacitidine Tablets 200 mg / 300 mg are prescription medicines intended for use only under medical supervision. The information provided on this page is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Patients should consult their healthcare provider for complete prescribing information. Cordium Pharmaceuticals Pvt. Ltd. Delivering Quality. Inspiring Care. Advancing Health.

Ibrance Capsules Overview Ibrance® (Palbociclib) is an oral targeted anticancer medication belonging to the CDK4/6 inhibitor class. It is used in combination with hormonal therapy for the treatment of HR-positive (Hormone Receptor Positive), HER2-negative advanced or metastatic breast cancer in adult patients. Palbociclib works by slowing down the growth and division of cancer cells, helping to control disease progression and improve treatment outcomes. At Cordium Pharmaceuticals Pvt Ltd, we are committed to supplying high-quality oncology medicines that support effective cancer care worldwide. Available Strengths Ibrance 75mg Capsules Ibrance 100mg Capsules Ibrance 125mg Capsules Active Ingredient: Palbociclib Dosage Form: Oral Capsules Uses of Ibrance Capsules Ibrance is prescribed for the treatment of: HR-Positive, HER2-Negative Advanced or Metastatic Breast Cancer It is commonly used in combination with: Aromatase inhibitors (such as letrozole) as first-line endocrine therapy Fulvestrant in patients whose cancer has progressed after hormonal therapy Other approved endocrine therapies as directed by an oncologist How Ibrance Works Palbociclib inhibits Cyclin-Dependent Kinases 4 and 6 (CDK4/6), proteins responsible for cell cycle progression. By blocking these proteins, Ibrance slows the multiplication of cancer cells and helps prevent tumor growth. Dosage and Administration Recommended Starting Dose 125 mg once daily for: 21 consecutive days of treatment Followed by 7 days off treatment This completes a 28-day treatment cycle. Dose Reduction Schedule If side effects occur, the treating physician may reduce the dose as follows: Dose Level Daily Dose Starting Dose 125 mg First Reduction 100 mg Second Reduction 75 mg Further reduction below 75 mg may require discontinuation of treatment. Administration Guidelines Take capsules with food. Swallow whole with water. Do not crush, chew, or open the capsules. Take at the same time each day. Follow your oncologist's instructions carefully. Precautions and Warnings Before taking Ibrance, inform your healthcare provider if you: Have liver disease or kidney impairment Have an active infection Experience fever or low blood cell counts Are pregnant or planning pregnancy Are breastfeeding Are taking prescription medicines, herbal supplements, or CYP3A-interacting drugs Important Monitoring Regular blood tests are required to monitor: White blood cell count Neutrophil count Red blood cells Platelets Liver function Dose interruptions or adjustments may be necessary based on laboratory results. Pregnancy Warning Ibrance may cause harm to an unborn baby. Effective contraception should be used during treatment and for the recommended period after therapy completion. Breastfeeding is not advised during treatment. Side Effects of Ibrance Capsules Like all cancer medicines, Ibrance may cause side effects. Common Side Effects Low white blood cell count (Neutropenia) Fatigue Nausea Diarrhea Hair thinning or hair loss Mouth sores (Stomatitis) Infections Decreased appetite Weakness Anemia Low platelet count Serious Side Effects Seek immediate medical attention if you experience: Fever or signs of infection Severe shortness of breath Persistent cough Chest pain Severe allergic reactions Unusual bleeding or bruising Serious cases of interstitial lung disease (ILD) and pneumonitis have been reported in some patients. Storage Information Store below 30°C. Keep away from moisture and direct sunlight. Keep out of reach of children. Do not use expired medication. Why Choose Cordium Pharmaceuticals Pvt Ltd? Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical company dedicated to providing quality oncology medicines and healthcare solutions. We focus on: High-quality pharmaceutical products Reliable global supply chain Regulatory compliance Patient-centric healthcare solutions Competitive pricing for international markets Frequently Asked Questions (FAQs) What is Ibrance used for? Ibrance is used to treat HR-positive, HER2-negative advanced or metastatic breast cancer in combination with hormone therapy. Can I take Ibrance without food? Ibrance capsules should be taken with food as directed by your healthcare provider. What are the available strengths of Ibrance? Ibrance capsules are available in 75mg, 100mg, and 125mg strengths. What is the most common side effect? Neutropenia (low white blood cell count) is one of the most frequently reported side effects and requires regular monitoring. Disclaimer This information is intended for educational purposes only and should not replace professional medical advice. Always consult a qualified oncologist before starting or modifying any cancer treatment.